检索结果 - Jyh-Pyng Gau

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma

    Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma 由 Pei Hsu, Ting‐Wei Lin, Jyh‐Pyng Gau, Yuan‐Bin Yu, Liang‐Tsai Hsiao, Cheng‐Hwai Tzeng, Po‐Min Chen, Tzeon-Jye Chiou, Liu H, Yao‐Chung Liu, Chia‐Jen Liu

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B

    Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B 由 Yi‐Hsiang Huang, Liang-Tsai Hsiao, Ying-Chung Hong, Tzeon-Jye Chiou, Yuan-Bin Yu, Jyh-Pyng Gau, Chun‐Yu Liu, Muh‐Hwa Yang, Cheng‐Hwai Tzeng, Pui-Ching Lee, Han‐Chieh Lin, Shou‐Dong Lee

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation

    Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation 由 Yao‐Chung Liu, Sheng‐Hsuan Chien, Nai‐Wen Fan, Ming‐Hung Hu, Jyh‐Pyng Gau, Chia-Jen Liu, Yuan‐Bin Yu, Chun‐Yu Liu, Liang‐Tsai Hsiao, Liu H, Tzeon‐Jye Chiou, Po‐Min Chen, Cheng‐Hwai Tzeng

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

    Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment... 由 Hagop M. Kantarjian, Xavier Thomas, Anna Dmoszyńska, Agnieszka Wierzbowska, Grzegorz Mazur, Jiří Mayer, Jyh-Pyng Gau, Wen‐Chien Chou, Rena Buckstein, Jaroslav Čermák, Ching-Yuan Kuo, Albert Oriol, Farhad Ravandi, Stefan Faderl, Jacques Delaunay, Daniel Lysák, Mark D. Minden, Christopher Arthur

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma

    A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma 由 Chia‐Jen Liu, Shinn‐Yn Lin, Ching‐Fen Yang, Chiu‐Mei Yeh, Ai‐Seon Kuan, Hao‐Yuan Wang, Chun‐Kuang Tsai, Jyh‐Pyng Gau, Liang‐Tsai Hsiao, Po‐Min Chen, Yao‐Chung Liu, Ying‐Chung Hong, Po‐Shen Ko, Liu H, Chia‐Hsin Lin

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

    Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial 由 Yuqin Song, Hervé Tilly, Shinya Rai, Huilai Zhang, Jie Jin, Hideki Goto, Yasuhito Terui, Ho‐Jin Shin, Won Seog Kim, Junning Cao, Jifeng Feng, Hyeon‐Seok Eom, Tae Min Kim, Cheng‐Hong Tsai, Jyh‐Pyng Gau, Hideo Koh, Liling Zhang, Yongping Song, Yu Yang, Wei Li, He Huang, Kiyoshi Ando, Jeff P. Sharman, Laurie H. Sehn, Lilian Bu, Xin Wang, Yanwen Jiang, Jamie Hirata, Calvin Lee, Jun Zhu, Koji Izutsu

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

    Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma 由 Hervé Tilly, Franck Morschhauser, Laurie H. Sehn, Jonathan W. Friedberg, Marek Trněný, Jeff P. Sharman, Charles Herbaux, John M. Burke, Matthew J. Matasar, Shinya Rai, Koji Izutsu, Neha Mehta–Shah, Lucie Obéric, Adrien Chauchet, Wojciech Jurczak, Yuqin Song, Richard Greil, Larysa Mykhalska, Juan Bergua, Matthew C. Cheung, Antonio Pinto, Ho‐Jin Shin, Greg Hapgood, Eduardo Munhoz, Pau Abrisqueta, Jyh‐Pyng Gau, Jamie Hirata, Yanwen Jiang, Mark Yan, Calvin Lee, Christopher R. Flowers, Gilles Salles

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

    The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and P... 由 Hervé Tilly, Franck Morschhauser, Laurie H. Sehn, Jonathan W. Friedberg, Marek Trněný, Jeff P. Sharman, Charles Herbaux, John M. Burke, Matthew J. Matasar, Shinya Rai, Koji Izutsu, Neha Mehta–Shah, Lucie Obéric, Adrien Chauchet, Wojciech Jurczak, Yuqin Song, Richard Greil, Larysa Mykhalska, Juan Miguel Bergua Burgués, Matthew C. Cheung, Antonio Pinto, Ho‐Jin Shin, Greg Hapgood, Eduardo Munhoz, Pau Abrisqueta Costa, Jyh‐Pyng Gau, Jamie Hirata, Yanwen Jiang, Mark Yan, Calvin Lee, Christopher R. Flowers, Gilles Salles

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: